bupropion has been researched along with Lung Neoplasms in 13 studies
Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.
Lung Neoplasms: Tumors or cancer of the LUNG.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aim of this study was to assess the cost-effectiveness of varenicline compared with other existing strategies for smoking cessation within a 10-year time horizon in an adult population cohort from Central American and Caribbean countries using the health care payer's perspective." | 7.78 | Cost-effectiveness analysis of varenicline versus existing smoking cessation strategies in Central America and the Caribbean using the BENESCO model. ( Cuesta, G; Lovato, P; Lutz, MA, 2012) |
| "To calculate incremental cost-utility ratios (cost per quality-adjusted life-year [QALY] gained) for bupropion (Zyban; GlaxoSmithKline; Gothenburg, Sweden), as compared to nicotine replacement therapy (NRT) in smoking cessation programs for a follow-up period of 20 years." | 7.73 | The cost utility of bupropion in smoking cessation health programs: simulation model results for Sweden. ( Bolin, K; Lindgren, B; Willers, S, 2006) |
| " Primary intervention for smoking cessation begins with systematic identification of smokers and a formal diagnosis of nicotine dependence." | 4.80 | New developments in smoking cessation. ( Prochazka, AV, 2000) |
| " The aim of this study was to assess the cost-effectiveness of varenicline compared with other existing strategies for smoking cessation within a 10-year time horizon in an adult population cohort from Central American and Caribbean countries using the health care payer's perspective." | 3.78 | Cost-effectiveness analysis of varenicline versus existing smoking cessation strategies in Central America and the Caribbean using the BENESCO model. ( Cuesta, G; Lovato, P; Lutz, MA, 2012) |
| " The aim of this study was to compare the direct medical costs of smoking cessation therapies with varenicline, bupropion, nicotine replacement therapy, and unaided cessation in Nicaragua over 5 time horizons: 2, 5, 10, and 20 years, and lifetime." | 3.78 | Cost analysis of varenicline versus bupropion, nicotine replacement therapy, and unaided cessation in Nicaragua. ( Cuesta, G; Lovato, P; Lutz, MA, 2012) |
| "To calculate incremental cost-utility ratios (cost per quality-adjusted life-year [QALY] gained) for bupropion (Zyban; GlaxoSmithKline; Gothenburg, Sweden), as compared to nicotine replacement therapy (NRT) in smoking cessation programs for a follow-up period of 20 years." | 3.73 | The cost utility of bupropion in smoking cessation health programs: simulation model results for Sweden. ( Bolin, K; Lindgren, B; Willers, S, 2006) |
| "Optimal treatment of lung cancer includes attention to continued tobacco use, with abstinence contributing to improved patient-related outcomes at various phases of lung cancer management." | 2.49 | Treatment of tobacco use in lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. ( Evers-Casey, S; Leone, FT; Toll, BA; Vachani, A, 2013) |
| "A tobacco dependence treatment plan for lung cancer patients is provided." | 2.46 | Smoking cessation: an integral part of lung cancer treatment. ( Cataldo, JK; Dubey, S; Prochaska, JJ, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Thomas, NA | 1 |
| Ward, R | 1 |
| Tanner, NT | 1 |
| Rojewski, AM | 1 |
| Toll, B | 1 |
| Gebregziabher, M | 1 |
| Silvestri, GA | 1 |
| Gaddey, HL | 3 |
| Dakkak, M | 3 |
| Jackson, NM | 3 |
| Tsai, CJ | 1 |
| Chiu, WC | 1 |
| Chen, CJ | 1 |
| Chen, PC | 1 |
| McIntyre, RS | 1 |
| Chen, VC | 1 |
| Kathuria, H | 1 |
| Leone, FT | 2 |
| Neptune, ER | 1 |
| Evers-Casey, S | 1 |
| Toll, BA | 1 |
| Vachani, A | 1 |
| Cataldo, JK | 1 |
| Dubey, S | 1 |
| Prochaska, JJ | 1 |
| Lutz, MA | 2 |
| Lovato, P | 2 |
| Cuesta, G | 2 |
| Westmaas, JL | 1 |
| Brandon, TH | 1 |
| Bolin, K | 1 |
| Lindgren, B | 1 |
| Willers, S | 1 |
| Schnoll, RA | 1 |
| Patterson, F | 1 |
| Lerman, C | 1 |
| Cooley, ME | 1 |
| Sipples, RL | 1 |
| Murphy, M | 1 |
| Sarna, L | 1 |
| Prochazka, AV | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Dyad-based Multiple Behavior Intervention for Reducing Lung Cancer Symptoms - a Pilot Randomized Control Trial (Breathe Easier II)[NCT05956782] | 60 participants (Anticipated) | Interventional | 2022-06-15 | Recruiting | |||
| The Effect of Motivational Interview Attempt on Self-Efficacy Level and Decision to Quit Smoking of University Students[NCT05324644] | 64 participants (Actual) | Interventional | 2021-04-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 reviews available for bupropion and Lung Neoplasms
| Article | Year |
|---|---|
Treatment of tobacco dependence: current state of the art.
Topics: Bupropion; Directive Counseling; Early Detection of Cancer; Humans; Lung Neoplasms; Smoking Cessatio | 2018 |
Treatment of tobacco use in lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Counseling; Evidence-Based Medicine; Humans; Lu | 2013 |
Smoking cessation: an integral part of lung cancer treatment.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Female; Humans; Lung Neoplasms; Male; Middle Ag | 2010 |
Reducing risk in smokers.
Topics: Bupropion; Chewing Gum; Counseling; Dopamine Uptake Inhibitors; Humans; Lung Neoplasms; Nicotine; Ri | 2004 |
Treating tobacco dependence in women.
Topics: Benzazepines; Bupropion; Counseling; Dopamine Uptake Inhibitors; Female; Humans; Lung Neoplasms; Nic | 2007 |
Smoking cessation and lung cancer: oncology nurses can make a difference.
Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Information Services; Lung Neoplasms; N | 2008 |
New developments in smoking cessation.
Topics: Administration, Cutaneous; Antidepressive Agents; Behavior Therapy; Bupropion; Counseling; Humans; L | 2000 |
1 trial available for bupropion and Lung Neoplasms
| Article | Year |
|---|---|
Factors Associated With Smoking Cessation Attempts in Lung Cancer Screening: A Secondary Analysis of the National Lung Screening Trial.
Topics: Bupropion; Early Detection of Cancer; Female; Humans; Lung; Lung Neoplasms; Male; Smoking Cessation; | 2023 |
5 other studies available for bupropion and Lung Neoplasms
| Article | Year |
|---|---|
Smoking Cessation Interventions.
Topics: Adolescent; Adult; Bupropion; Child; Early Detection of Cancer; Electronic Nicotine Delivery Systems | 2022 |
Smoking Cessation Interventions.
Topics: Adolescent; Adult; Bupropion; Child; Early Detection of Cancer; Electronic Nicotine Delivery Systems | 2022 |
Smoking Cessation Interventions.
Topics: Adolescent; Adult; Bupropion; Child; Early Detection of Cancer; Electronic Nicotine Delivery Systems | 2022 |
Smoking Cessation Interventions.
Topics: Adolescent; Adult; Bupropion; Child; Early Detection of Cancer; Electronic Nicotine Delivery Systems | 2022 |
Smoking Cessation Interventions.
Topics: Adolescent; Adult; Bupropion; Child; Early Detection of Cancer; Electronic Nicotine Delivery Systems | 2022 |
Smoking Cessation Interventions.
Topics: Adolescent; Adult; Bupropion; Child; Early Detection of Cancer; Electronic Nicotine Delivery Systems | 2022 |
Smoking Cessation Interventions.
Topics: Adolescent; Adult; Bupropion; Child; Early Detection of Cancer; Electronic Nicotine Delivery Systems | 2022 |
Smoking Cessation Interventions.
Topics: Adolescent; Adult; Bupropion; Child; Early Detection of Cancer; Electronic Nicotine Delivery Systems | 2022 |
Smoking Cessation Interventions.
Topics: Adolescent; Adult; Bupropion; Child; Early Detection of Cancer; Electronic Nicotine Delivery Systems | 2022 |
Antidepressant Prescription and Risk of Lung Cancer: A Nationwide Case-Control Study.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Case-Control Studies; Female; Humans; Longitudi | 2019 |
Cost-effectiveness analysis of varenicline versus existing smoking cessation strategies in Central America and the Caribbean using the BENESCO model.
Topics: Benzazepines; Bupropion; Cardiovascular Diseases; Central America; Cost-Benefit Analysis; Dominican | 2012 |
Cost analysis of varenicline versus bupropion, nicotine replacement therapy, and unaided cessation in Nicaragua.
Topics: Adolescent; Adult; Aged; Benzazepines; Bupropion; Coronary Disease; Costs and Cost Analysis; Dopamin | 2012 |
The cost utility of bupropion in smoking cessation health programs: simulation model results for Sweden.
Topics: Adult; Aged; Bupropion; Chewing Gum; Cost-Benefit Analysis; Dopamine Uptake Inhibitors; Female; Hear | 2006 |